T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Read more about T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 South Korea2023-7041691Filed on 2023-12-01
T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Read more about T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 China202280047288.0Filed on 2024-01-02
T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Read more about T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Australia2022268998Filed on 2023-12-05
T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Read more about T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Canada3217263Filed on 2023-10-30
T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Read more about T CELL RECEPTORS RECOGNIZING C135Y, R175H, OR M237I MUTATION IN P53 Japan2023-568469Filed on 2023-11-06
METHODS OF IDENTIFYING TARGETS OF CANCER DRUGS AND OF TREATING CANCER Read more about METHODS OF IDENTIFYING TARGETS OF CANCER DRUGS AND OF TREATING CANCER Patent Cooperation TreatyPCT/US2023/076704Filed on 2023-10-12
Glypican 2 As A Cancer Marker And Therapeutic Target Read more about Glypican 2 As A Cancer Marker And Therapeutic Target Japan2023-133443Filed on 2016-11-08
Directed acetylation of mRNA through engineered snoRNA adapters Read more about Directed acetylation of mRNA through engineered snoRNA adapters Patent Cooperation TreatyPCT/US2023/078830Filed on 2023-11-06
TOPOISOMERASE Ill (TOP3) INHIBITORS AND ANTIVIRAL COMPOUNDS BASED ON CYANINES Read more about TOPOISOMERASE Ill (TOP3) INHIBITORS AND ANTIVIRAL COMPOUNDS BASED ON CYANINES Patent Cooperation TreatyPCT/US2023/081638Filed on 2023-11-29
Topoisomerase Ill (TOP3) inhibitors and antiviral compounds based on bisacridines Read more about Topoisomerase Ill (TOP3) inhibitors and antiviral compounds based on bisacridines Patent Cooperation TreatyPCT/US2023/082186Filed on 2023-12-01